The Desk

AI-assisted analysis on every release · Page 307

Earnings
Quebec vape inventory reset drives sequential revenue dip; profitability holds but growth narrative stalls.

Jun 25, 2026 · 09:03 · MUSH · Mercanto Holdings Inc. · Neutral

01
Production / Operations
Adamera consolidates its Washington tungsten hub ahead of a 2027 U.S. defense deadline to secure critical supply chains.

Jun 25, 2026 · 09:01 · ADZ · Adamera Minerals Corp. · Routine +

02
Drill Results
Canuc’s East Sudbury drilling confirms high-grade gold continuity, underscoring the need for near-term capital execution to address going concern flags.

Jun 25, 2026 · 09:01 · CDA · Canuc Resources Corporation · Routine +

03
Other
Brand extension marketing adds zero near-term financial weight to a stock already discounting tariff headwinds and a sluggish Melissa & Doug turnaround.

Jun 25, 2026 · 09:00 · TOY · SPIN MASTER CORP. SV · Routine +

04
Drill Results
Fox Tungsten launches a 20,000m drill campaign at its Fox Project to support a 2027 preliminary economic assessment.

Jun 25, 2026 · 09:00 · FOXT · Fox Tungsten Ltd. · Routine +

05
Drill Results
Metals Creek’s High-Grade Ogden drill hit validates the structural model despite narrow width and going concern risks tempering near-term upside.

Jun 25, 2026 · 08:31 · MEK · Metals Creek Resources Corp. · Routine +

06
Other
Next-gen millimeter-wave screening for aviation and critical infrastructure, post-IPO scaling phase.

Jun 25, 2026 · 08:30 · SCAN · Liberty Defense Holdings, Ltd. · Routine +

07
Other
Pre-revenue MS developer navigates FDA clinical hold while doubling down on myelin-repair narrative and consumer-health royalties

Jun 25, 2026 · 08:30 · QNTM · Quantum BioPharma Ltd. · Neutral

08
Drill Results
Early-stage polymetallic explorer advancing Green Monster and Wildhorse projects in Nevada amid lower-than-expected assay grades.

Jun 25, 2026 · 08:30 · GSTR · Glenstar Minerals Inc. · Routine +

09
Drill Results
High-grade gold intercepts at Cole confirm continuity below historic workings, but cash burn and going concern risks persist.

Jun 25, 2026 · 08:30 · RKL · Rockland Resources Ltd. · Routine +

10
Other
Preclinical PNKP inhibitor developer burns cash and raises capital while marketing AI oncology partnerships to a niche market.

Jun 25, 2026 · 08:30 · ONCO · ONCO-INNOVATIONS LIMITED · Neutral

11
M&A / Property
Campus safety partnership validates commercial diversification, but margin compression and heavy SG&A burn keep the stock in a consolidation phase.

Jun 25, 2026 · 08:30 · DPRO · Draganfly Inc. · Routine +

12
Other
Israeli med-tech SaaS expands domestic footprint while navigating severe liquidity constraints and unproven U.S. commercialization.

Jun 25, 2026 · 08:30 · SEGN · Seegnal Inc. · Routine +

13
Technical Study
Anfield completes Phase I at Velvet-Wood and updates its PEA, confirming robust economics for its hub-and-spoke uranium-vanadium strategy.

Jun 25, 2026 · 08:17 · AEC · Anfield Energy Inc. · Routine +

14
Other
Regulatory clearance unlocks 2026 drilling campaign at Silver Vista, but exploration risk remains unmitigated until assay data validates the district-scale thesis.

Jun 25, 2026 · 08:11 · MAV · Maverick Gold and Silver Corporation · Routine +

15

← Newer Older →

The Desk

Quebec vape inventory reset drives sequential revenue dip; profitability holds but growth narrative stalls.

Adamera consolidates its Washington tungsten hub ahead of a 2027 U.S. defense deadline to secure critical supply chains.

Canuc’s East Sudbury drilling confirms high-grade gold continuity, underscoring the need for near-term capital execution to address going concern flags.

Brand extension marketing adds zero near-term financial weight to a stock already discounting tariff headwinds and a sluggish Melissa & Doug turnaround.

Fox Tungsten launches a 20,000m drill campaign at its Fox Project to support a 2027 preliminary economic assessment.

Metals Creek’s High-Grade Ogden drill hit validates the structural model despite narrow width and going concern risks tempering near-term upside.

Next-gen millimeter-wave screening for aviation and critical infrastructure, post-IPO scaling phase.

Pre-revenue MS developer navigates FDA clinical hold while doubling down on myelin-repair narrative and consumer-health royalties

Early-stage polymetallic explorer advancing Green Monster and Wildhorse projects in Nevada amid lower-than-expected assay grades.

High-grade gold intercepts at Cole confirm continuity below historic workings, but cash burn and going concern risks persist.

Preclinical PNKP inhibitor developer burns cash and raises capital while marketing AI oncology partnerships to a niche market.

Campus safety partnership validates commercial diversification, but margin compression and heavy SG&A burn keep the stock in a consolidation phase.

Israeli med-tech SaaS expands domestic footprint while navigating severe liquidity constraints and unproven U.S. commercialization.

Anfield completes Phase I at Velvet-Wood and updates its PEA, confirming robust economics for its hub-and-spoke uranium-vanadium strategy.

Regulatory clearance unlocks 2026 drilling campaign at Silver Vista, but exploration risk remains unmitigated until assay data validates the district-scale thesis.